Qi-Huang Zheng, Ph.D.
Dr. Qi-Huang Zheng's laboratory has been investigating the design, synthesis and biological evaluation of new radiopharmaceuticals (brain, tumor and heart imaging agents) for use in biomedical imaging technique positron emission tomography (PET) to study brain, cancer and cardiovascular diseases. His research interests range from PET radiopharmaceutical chemistry to synthetic organic chemistry and biologically active natural product chemistry. His current research activities focus on the development of novel and potent enzyme-based and/or receptor-based PET carbon-11 and fluorine-18 radiotracers for the qualitative and quantitative assessment of physiologic changes in vivo, from initial evaluation in cell and animal models to evaluation in clinical trails.
Doctorate: Zhongshan University, Guangzhou, P.R. of China
Postdoctoral Fellowship: The University of Chicago, Chicago, IL
Postdoctoral Fellowship: Indiana University-Purdue University, Indianapolis, IN